← Back to Clinical Trials
Recruiting NCT05701592
NCT05701592 Assessment of Outcomes of Double-bundle Posterior Cruciate Ligament Reconstruction (DB-PCLR)
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05701592 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konrad Malinowski MD |
| Condition | Posterior Cruciate Ligament Tear |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2022-12-20 |
| Primary Completion | 2025-12-31 |
Trial Parameters
Condition Posterior Cruciate Ligament Tear
Sponsor Konrad Malinowski MD
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-12-20
Completion 2025-12-31
Interventions
DB-PCLR
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Double-bundle Posterior Cruciate Ligament Reconstruction (DB-PCLR) is becoming increasingly used alternative to the single-bungle PCLR. While more technically challenging, it seems to better improve patients' outcomes. Therefore, outcomes of DB-PCLR will be assessed and reported.
Eligibility Criteria
Inclusion Criteria: * PCL tear with III grade sympomatic posterior instability confirmed clinically and radiologically * full knee range of motion Exclusion Criteria: * active knee inflammation * non-adherence to the study protocol * fixed posterior drawer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology